Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

42 results about "Cardiovascular functions" patented technology

The cardiovascular system, also known as the circulatory system, includes the heart, arteries, veins, capillaries and blood. The heart functions as the pump that moves blood through the body. The arterial circulation delivers blood from the heart to the body, and the venous circulation carries it back to the heart.

Coronary heart disease prediction method fusing cardiopulmonary motion parameter time sequence information

The invention discloses a coronary heart disease prediction method fusing cardiopulmonary motion parameter time sequence information. The coronary heart disease prediction method comprises the following steps: collecting multi-dimensional health data of a patient; carrying out preprocessing on the multi-dimensional health data; extracting features from the preprocessed data; performing time sequence analysis on the extracted features by using a deep learning model; and inputting the time sequence analysis result and the static characteristics into a classification model for coronary heart disease prediction, outputting a prediction result and generating a related health report. The method comprises the following steps: acquiring demographic data, basic medical information and cardiopulmonary exercise test data of a target object, specifically including parameters such as age, gender, body mass index, social economics information, past history, complication, clinical examination and examination, athletic ability, cardiovascular function, ventilation perfusion and the like; the coronary heart disease is predicted by fusing the static parameters and the time sequence information, the dynamic change in the health data of the patient can be better captured, and the prediction accuracy is improved.
Owner:SOUTH CHINA UNIV OF TECH

Personalized chest acceleration derived prediction of cardiovascular abnormalities using deep learning

PendingUS20250040894A1Medical automated diagnosisSensorsMedicineCARDIOVASCULAR ABNORMALITY
A system and method for predicting cardiovascular function is presented. The method includes accessing physiological measurement data and patient data from a patient. The method also includes accessing a neural network trained to predict cardiovascular function data using the physiological measurement data and patient data.
Owner:NORTHWESTERN UNIV

Automatic alarm system for cardiovascular medicine department

The invention relates to the technical field of cardiovascular medicine, in particular to an automatic alarm system for cardiovascular medicine, which comprises a biomarker analysis module, a physiological parameter analysis module, a cardiovascular risk assessment module, a cardiovascular early warning adjustment module and an alarm trigger notification module. According to the invention, by integrating real-time monitoring of blood biomarkers and cardiovascular physiological parameters, the early recognition capability of cardiovascular disease risks is improved, key biomarkers are dynamically measured and compared with historical marker data, and subtle physiological changes can be captured at the early stage of asymptomatic conditions, so that potential cardiovascular events are warned; through correlation analysis of electrocardiogram, blood pressure and pulse waveforms, the system can accurately draw a comprehensive image of cardiovascular functions, so that more targeted monitoring and intervention are implemented, timeliness and accuracy of medical response are ensured, doctors can formulate targeted monitoring schemes according to real-time data, and the monitoring efficiency is improved. Therefore, deterioration or occurrence of cardiovascular events of patients can be effectively prevented.
Owner:NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY

Cardiovascular assist system that quantifies heart function and facilitates heart recovery

The systems, devices, and methods presented herein use a heart pump to obtain measurements of cardiovascular function. The heart pumps described herein can operate in parallel with and unload the heart. The system can quantify the functioning of the native heart by measuring certain parameters / signals such as pressure or motor current, then calculate and display one or more metrics of cardiovascular function. These metrics, such as left ventricular end diastolic pressure (LVEDP), left ventricular pressure, and contractility, provide valuable information to a user regarding a patient's state of heart function and recovery.
Owner:ABIOMED INC +1

Novel polypeptide capable of regulating activity of AMPK (adenosine monophosphate kinase) and pharmaceutical application of novel polypeptide

The invention relates to the technical field of biological medicine, in particular to a novel polypeptide and application thereof in medicine for treating cardiovascular diseases. The polypeptide has a unique amino acid sequence, and is composed of an amino acid sequence of SEQ. NO: 1: Leu-Asn-Pro-Thr-Glu (LNPTG), an amino acid sequence of SEQ. NO: 2: Val-His-Met-Arg-Tyr (VHMRY), and the like. The polypeptide has a unique amino acid sequence, and provides a new way for the treatment of cardiovascular diseases by adjusting the activity of AMPK and improving the cardiovascular function.
Owner:ZHEJIANG GUOBEN PHARM GRP CO LTD

Application of dendrobium extract in preparation of medicine for treating type 2 diabetes mellitus

The invention discloses an application of a dendrobium extract in preparation of a medicine for treating type 2 diabetes, and mainly relates to the technical field of dendrobium. Particularly, the invention provides the dendrobium extract-containing medicine for treating the type 2 diabetes, so that the stability of components applied to the medicine for treating the type 2 diabetes in acidic, neutral and alkaline environments is improved, and the blood sugar rising amplitude is slowed down. Compared with the prior art, the medicine for treating type 2 diabetes mellitus prepared by the invention takes the dendrobium extract as a core and is matched with the synergistic emulsion, the rhizoma polygonati extract, the dogwood extract, the radix salviae miltiorrhizae extract, the bitter gourd extract, the vitamin B and the trace element chromium element; the traditional Chinese medicine composition disclosed by the invention can be used for synergistically regulating blood sugar metabolism, enhancing insulin sensitivity, improving microcirculation, stabilizing blood sugar, improving insulin resistance and lipid metabolism and enhancing immunity and cardiovascular functions, and a safe and effective medicine is provided for preventing and treating type II diabetes.
Owner:PENGJUN (GUANGZHOU) BIOTECHNOLOGY CO LTD

Hearing aid health analysis method based on physiological signal monitoring function

The invention discloses a hearing aid health analysis method based on a physiological signal monitoring function. The method comprises the following steps: collecting physiological signal data of a user in real time through a multi-mode biosensor array integrated on a hearing aid body; the hearing aid body comprises a digital signal processor and a wireless communication module; the physiological signal data at least comprises a brain wave signal, a skin electric response signal and a temporal artery pulse signal; performing motion artifact elimination processing on the physiological signal data through an adaptive filtering algorithm; performing feature extraction on the preprocessed physiological signal by using an embedded health analysis engine to generate a composite health feature vector containing a sympathetic nerve activity index, cognitive load measurement and a cardiovascular function index; and dynamically generating a health risk assessment report based on an association relationship between the composite health feature vector and a preset hearing scene, the bone conduction vibration unit and the audio synthesis module of the hearing aid body output graded health alarm signals.
Owner:SHENZHEN XINZHENGYU TECH

Cardiovascular function enhancing device for preventing cardiovascular diseases

The invention relates to the technical field of cardiovascular function enhancement, and provides a cardiovascular function enhancement device for preventing cardiovascular diseases in order to solve the problems that an existing cardiovascular function enhancement device can only carry out one type of exercise, and the balance weight cannot be adjusted according to personal requirements during training. Comprising a base and a bottom plate arranged on the base, and further comprises a supporting seat arranged on the bottom plate; the load mechanism is arranged above the supporting seat, penetrates through the supporting column and is used for providing a resistance load; the pedal mechanism is arranged in the middle of the base and is used for the patient to tread to generate force to simulate lower limb movement; and the pulley mechanism is used for connecting the pedal mechanism and the load mechanism to realize synchronous matching between the pedal mechanism and the load mechanism. According to the cardiovascular function training device, simulation of multiple motion modes can be provided, and the resistance load can be flexibly adjusted according to personal requirements, so that precise and personalized cardiovascular function training is achieved.
Owner:THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM

CTPER polypeptide and application thereof in medicine for treating cardiovascular diseases

The invention relates to the technical field of biological medicine, in particular to a novel polypeptide and application thereof in medicine for treating cardiovascular diseases. The polypeptide has a unique amino acid sequence and is composed of an amino acid sequence SEQ.NO: 1: Cys-Tyr-Pro-Glu-Arg (CTPER), an amino acid sequence SEQ.NO: 2: Asn-His-Met-Val-Asp (NHVD) and the like, and the cardiovascular function is improved by adjusting a nuclear factor kappa B (NF-kappa B) signal channel.
Owner:ZHEJIANG GUOBEN PHARM GRP CO LTD

Hearing aid health analysis method based on physiological signal monitoring function

The application discloses a hearing aid health analysis method based on physiological signal monitoring function, comprising the following steps: collecting physiological signal data of a user in real time through a multi-modal biological sensor array integrated in a hearing aid body; the hearing aid body comprises a digital signal processor and a wireless communication module; the physiological signal data at least comprises an electroencephalogram signal, a galvanic skin response signal and a temporal artery pulse signal; the physiological signal data is subjected to motion artifact elimination processing through an adaptive filtering algorithm; a preprocessed physiological signal is subjected to feature extraction through an embedded health analysis engine, and a composite health feature vector comprising a sympathetic nerve activity index, a cognitive load metric and a cardiovascular function index is generated; a health risk assessment report is dynamically generated based on the association between the composite health feature vector and a preset hearing scene; and a graded health alarm signal is output through a bone conduction vibration unit and an audio synthesis module of the hearing aid body.
Owner:SHENZHEN XINZHENGYU TECH

Coenzyme Q10 preparation for improving myocardial cell activity and cardiovascular function and preparation method thereof

The invention relates to the technical field of coenzyme Q10 preparations, and discloses a coenzyme Q10 preparation for improving myocardial cell activity and cardiovascular function, and the coenzyme Q10 preparation comprises the following components in percentage by mass according to 1 liter of prescription: 0.1-10% of coenzyme Q10, 0.5-30% of emulsifier, 5-20% of co-emulsifier, 0.5-10% of stabilizer, 5% of glucose, 0.9% of sodium chloride, 0.25% of absolute ethyl alcohol and the balance of water, according to the coenzyme Q10 preparation for improving the myocardial cell activity and the cardiovascular function, preparation of the coenzyme Q10 preparation is completed, so that the obtained coenzyme Q10 preparation has the functions of enhancing physical ability and vigor, protecting the cardiovascular system, reducing side effects of lipid-lowering drugs, protecting the skin and the like, and the coenzyme Q10 preparation can improve the myocardial function and improve cardiovascular diseases; the heart is prevented from being damaged by oxidative stress.
Owner:SHANDONG GUOHETANG PHARM CO LTD

Novel STPEN polypeptide and application thereof in improving cardiovascular medicine

The invention relates to the technical field of biological medicine, and provides a novel STPEN polypeptide and application thereof to cardiovascular improvement medicine, the polypeptide has a unique amino acid sequence, the polypeptide is composed of amino acid sequences SEQ.NO: 1, Ser-Thr-Pro-Glu-Asn (STPEN) and SEQ.NO: 2, His-Lys-Met-Val-Asp (HKMVD), and the polypeptide is used for adjusting the activity of angiotensin converting enzyme 2 (ACE2), improving the cardiovascular function and improving the cardiovascular function. And a new way is provided for the treatment of cardiovascular diseases.
Owner:ZHEJIANG GUOBEN PHARM GRP CO LTD

Assessment of cardiovascular function through concomitant acquisition of ECG and bia

Methods and systems for assessing cardiovascular functions of a patient are described. The method comprises acquiring ECG data and BIA data concomitantly through a plurality of electrodes positioned in an ECG configuration, predicting parameters of cardiovascular function from the ECG data and the BIA data using deep learning algorithms, and outputting surrogates of parameters of cardiovascular functions in a clinical format.
Owner:MCGILL UNIV

Composition capable of improving cardiovascular function and preparation method and application thereof

The invention discloses a composition capable of improving cardiovascular functions as well as a preparation method and application of the composition, belongs to the field of health-care foods, and aims to provide a composition capable of assisting in enhancing physical strength, improving immunity, improving cardiovascular capabilities and delaying vascular aging. The composition comprises L-arginine, beet powder, vitamin C, vitamin E, a garlic extract, a black tea extract and a lotus seed extract as main active ingredients. The optimal content range of each component is determined through experimental research of different proportions, and animal experiments prove that the traditional Chinese medicine composition has remarkable effects of improving physical strength, hypoxia tolerance and immunity of mice. The invention not only provides a new health-care choice for improving the health condition of a human body, but also has an important application value for preventing diseases related to cardiovascular and immunity.
Owner:SHANDONG BAYUAN BIOTECHNOLOGY CO LTD

Composition containing sacubitril valsartan sodium and feneglitazone and preparation method thereof

The invention discloses a composition containing sacubitril-valsartan sodium and fineglitazone and a preparation method thereof, and relates to the technical field of medicines, the composition is composed of sacubitril-valsartan sodium, fineglitazone, a flavoring agent, a taste masking agent, a liposome carrier, a blood vessel protective agent, a synergist, a filler, a disintegrating agent, a lubricant and an adhesive; according to the sacubitril-valsartan sodium tablet and the preparation method thereof, active ingredients of sacubitril sodium and fineglitazone are accurately proportioned, various auxiliary materials such as the flavoring agent, the taste masking agent and the liposome carrier are introduced, the curative effect of the medicine and the medication experience of a patient are greatly improved, sacubitril-valsartan sodium serving as a compound preparation has strong blood pressure lowering and cardiovascular protection effects, and the sacubitril-valsartan sodium tablet is suitable for clinical application. The composition can further improve the cardiovascular function, and the composition and the fipronil have a synergistic effect, so that the composition has excellent performance in the aspect of treating cardiovascular diseases.
Owner:JIANGSU VANGUARD PHARM CO LTD

A method for predicting coronary heart disease by fusing heart-lung motion parameter time series information

The application discloses a coronary heart disease prediction method fusing cardiopulmonary exercise parameter time sequence information, and comprises the following steps: collecting multidimensional health data of a patient; preprocessing the multidimensional health data; extracting features from the preprocessed data; performing time sequence analysis on the extracted features by using a deep learning model; inputting the time sequence analysis result and static features into a classification model to perform coronary heart disease prediction, outputting a prediction result and generating a related health report. By acquiring demographic data, basic medical information and cardiopulmonary exercise test data of a target object, specifically including age, gender, body mass index, socio-economic information, past history, complications, clinical examination and inspection, exercise capacity, cardiovascular function and ventilation perfusion and the like, the coronary heart disease is predicted by fusing static parameters and time sequence information, so that dynamic changes in the health data of the patient can be better captured, and the prediction accuracy is improved.
Owner:SOUTH CHINA UNIV OF TECH

Cardiovascular assist system that quantifies heart function and facilitates heart recovery

The systems, devices, and methods presented herein use a heart pump to obtain measurements of cardiovascular function. The heart pumps described herein can operate in parallel with and unload the heart. The system can quantify the functioning of the native heart by measuring certain parameters / signals such as pressure or motor current, then calculate and display one or more metrics of cardiovascular function. These metrics, such as left ventricular end diastolic pressure (LVEDP), left ventricular pressure, and contractility, provide valuable information to a user regarding a patient's state of heart function and recovery.
Owner:ABIOMED INC +1

Methods for improving cardiovascular function and treating cardiovascular disease using recombinant ectonucleotide pyrophosphatase / phosphodiesterase (NPP1)

To provide methods for improving the cardiovascular function and treating a cardiovascular disease using recombinant ectonucleotide pyrophosphatase / phosphodiesterase (NPP1).SOLUTION: The present invention provides methods for improving the cardiovascular function in a human patient (e.g., reducing hypertension) and methods of treating a cardiovascular disease, by administering a recombinant human soluble ectonucleotide pyrophosphatase / phosphodiesterase (hsNPP1) or an active fragment or fusion protein thereof. In one embodiment, the improvement is a reduction in elevated blood pressure (e.g., a reduction in blood pressure higher than 140 / 90 millimeters of mercury (mmHg) to within a normal blood pressure range, namely, about 120 / 80 mm of mercury (mmHg)).SELECTED DRAWING: None
Owner:INOZYME PHARMA INC

System and method for cardiovascular monitoring and reporting

A system and method for cardiovascular monitoring and reporting are disclosed. The system (CV monitoring system) includes a data analysis system and an in-ear biosensor system that preferably includes left and right earbuds. The earbuds include infrasound / vibration sensors that detect biosignals from the individual including signals associated with cardiovascular activity (CV signals). The analysis system calculates cardiovascular function measurements (CV function measurements) based upon the CV signals. The CV monitoring system uses machine learning to predict blood pressure (BP) measurements of the individual based upon the CV signals and the calculated CV function measurements. In an embodiment, the CV monitoring system includes an EKG detection system that detects EKG signals associated with heart function. The analysis system can calculate additional CV function measurements from the EKG signals to augment the CV function measurements calculated from the CV signals, and predict BP measurements using the full complement of CV function measurements.
Owner:BARNACKA ANNA +2

Special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance and preparation method thereof

The invention discloses a special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance and a preparation method thereof, and the special diet comprises the following components in parts by weight: 2-4 parts of bone collagen peptide, 1-2 parts of taurine, 2-3 parts of hydrolyzed collagen peptide, 1-2 parts of marine fish oligopeptide, 1-2 parts of inulin, 1-2 parts of erythritol, 2-3 parts of acerola cherry fruit powder and 2-3 parts of guarana extract. 1-2 parts of N-acetylneuraminic acid, 1-2 parts of vitamin C, 1-2 parts of vitamin B6, 1-2 parts of vitamin B1 and 1-2 parts of vitamin B2; the traditional Chinese medicine composition can improve cardiovascular functions and microcirculation disturbance, and has remarkable effects in the aspects of inhibiting cardiovascular diseases, promoting microcirculation and enhancing immunity.
Owner:XINCAI GOLDEN PARTNER HEALTH TECH CO LTD

Active substance for strengthening cardiovascular functions of dogs and cats and preparation method and application of soft capsule

The invention discloses an active substance for strengthening cardiovascular functions of dogs and cats and a preparation method and application of soft capsules, and relates to the technical field of animal health care products. The composition comprises components such as kelp powder extract, coix seed extract, Omega-3 fatty acid, coenzyme Q10, L-carnitine, vitamin B6, vitamin E and the like, and the components jointly act on proliferation, metabolism and transcription processes of vascular endothelial cells of dogs and cats. Through in-vitro metabonomics and transcriptomics analysis, the composition has the effects of promoting proliferation of vascular endothelial cells of dogs and cats, increasing cell elasticity, reducing the risk of thrombus and sclerosis and the like. In addition, the invention also provides application of the composition in preparation of food for strengthening cardiovascular functions of dogs and cats. Compared with the prior art, the composition provided by the invention can provide an effective health-care strategy and can remarkably promote cardiovascular functions of dogs and cats.
Owner:WUHU WEISHI BIOTECHNOLOGY CO LTD +3

Implantable smartport for ultrasonic, electrical, and optical monitoring of cardiac functions during chemotherapy

This invention in one aspect discloses a smartport system that can continuously monitor cardiovascular function during chemotherapy sessions through ECG and dynamic ejection fraction measurements via ultrasound probes. Ultrasound probes monitor the patency of the catheter shaft through Doppler measurements of the flow. Monitoring heart function and patency of the catheter shaft are unmet needs for chemotherapy patients who receive drugs via portacath systems. This monitoring allows immediate real-time assessment of the cardiotoxicity of cytotoxic chemotherapeutic therapies.
Owner:NORTHWESTERN UNIV

Composition for delaying senescence, preventing and resisting cancer and resisting cardiovascular and cerebrovascular diseases and preparation method thereof

The invention discloses a composition for delaying senescence, preventing and resisting cancers and resisting cardiovascular and cerebrovascular diseases and a preparation method thereof. The composition comprises the following components in parts by weight: nicotinamide, DHA algae oil powder, phosphatidylserine, myocardial polypeptide, folic acid, a broccoli seed water extract, microcrystalline cellulose, vitamin B1 and vitamin B2. The traditional Chinese medicine composition can improve the cardiovascular function, has the functions of enhancing the immunity of cancer cells, regulating metabolism and resisting aging, and can achieve remarkable effects in the aspects of inhibiting cardiovascular and cerebrovascular diseases, resisting cancers, preventing cancers and delaying aging on the basis of regulating the immunity.
Owner:XINCAI GOLDEN PARTNER HEALTH TECH CO LTD

Optimization of drug combinations for the treatment of acute heart failure

The embodiments disclosed herein can include an operation of receiving a plurality of current cardiovascular function metrics of a patient and a plurality of candidate drugs to be used to reach a plurality of desired cardiovascular function metrics, and an operation of determining an optimal dosage of the plurality of candidate drugs to reach the plurality of desired cardiovascular function metrics. Determining can include optimizing a dosage combination of the plurality of candidate drugs to reach a plurality of desired cardiovascular parameters corresponding to the plurality of desired cardiovascular function metrics from a plurality of current cardiovascular parameters corresponding to the plurality of current cardiovascular function metrics, and mapping a plurality of desired cardiovascular function metrics from the plurality of desired cardiovascular parameters and a plurality of current cardiovascular function metrics from the plurality of current cardiovascular parameters. The operation can further include outputting an optimal dosage of the plurality of candidate drugs.
Owner:NTT RESEARCH INC

Noninvasive blood pressure waveform reconstruction method based on 3D blood vessel modeling and depth sequential network

The invention provides a non-invasive blood pressure waveform reconstruction method based on 3D blood vessel modeling and a depth sequential network, and belongs to the field of non-invasive physiological signal processing and cardiovascular function evaluation. The method comprises the following steps: constructing a physiological simulation model containing a vascular network from a radial artery to a fingertip by adopting VTK; the method comprises the following steps: integrating a Moens-Korteweg wave equation, a vascular compliance model and a Beer-Lambert optical law, and establishing a signal conversion model from ABP to PPG; designing a deep sequential network architecture comprising a U2-Net nested U-shaped structure and a bidirectional time processor (BTP); aBP waveform reconstruction is realized through a depth supervision strategy and a combined loss function; and finally, closed-loop application is realized in a hardware system integrated with the MAX30102 sensor and the STM32F103 processor. Experiments show that according to the method, the prediction precision of SBP 2.48 + / -1.95 mmHg and DBP 1.42 + / -1.42 mmHg is achieved in an MIMICII data set, and the AAMI standard is achieved. Through combination of theoretical modeling and an intelligent algorithm and implementation of a hardware system, a novel noninvasive monitoring scheme is provided for family health monitoring.
Owner:GUILIN UNIV OF ELECTRONIC TECH

A method for pulse feature extraction in cardiovascular function assessment of depressive patients

This invention relates to the field of medical data processing technology, specifically to a method for extracting pulse features for assessing cardiovascular function in patients with depression. The method first acquires the subject's electrocardiogram (ECG) signal and two-dimensional pulse signals at various radial artery pulse reference points; based on the pulse propagation delay and attenuation between these reference points, a spatial discoordination index is determined; the envelope phase difference of the diastolic two-dimensional pulse signal is extracted and, combined with the spatial discoordination index, an arterial spasm index is determined; the correlation between the subject's heart rate intensity and pulse arrival time is analyzed to determine an autonomic nervous system regulation efficiency index; the rate of change of the arterial spasm index and the autonomic nervous system regulation efficiency index is combined to determine neurovascular decompensation indicators; and the temporal correlation between the decompensation indicators and the arterial spasm index is analyzed to determine cardiovascular function risk factors for depression. This invention improves the accuracy of cardiovascular function assessment.
Owner:西安国际医学中心有限公司

Rodent Cardiovascular Exercise Tester

1. The name of this design product: Rodent cardiovascular exercise tester. 2. Purpose of this design product: It is used to test and analyze the cardiovascular function of experimental animals such as mice by simulating a sports environment, serving the field of biomedical research. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.
Owner:GUANGDONG MEDICAL UNIV

High and low oxygen training instrument

1. The name of the design product: High and low oxygen training instrument. 2. The use of the design product: A device for automatically switching between low oxygen and oxygen-rich states, continuously recording patient data, enhancing cardiovascular function, improving physical fitness, etc. 3. The design key points of the design product: lies in the shape. 4. The picture or photo that best shows the design key points: Perspective view 1.
Owner:ANYANG XIANGYU MEDICAL EQUIP